Home
About
Overview
Sharing Data
ORCID
Help
History (55)
Prolonged survival and response to tepotinib in a non-small-cell lung cancer patient with brain metastases harboring MET exon 14 mutation: a research report.
Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches.
Integration of artificial intelligence in lung cancer: Rise of the machine.
The expanding role of the receptor tyrosine kinase MET as a therapeutic target in non-small cell lung cancer.
Small cell lung cancer: from molecular biology to novel therapeutics.
See All 55 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Small cell lung cancer: from molecular biology to novel therapeutics.
Small cell lung cancer: from molecular biology to novel therapeutics. J Exp Ther Oncol. 2003 Nov-Dec; 3(6):305-18.
View in:
PubMed
subject areas
Carcinoma, Small Cell
Combined Modality Therapy
Humans
Lung Neoplasms
authors with profiles
Ravi Salgia